Cohance Lifesciences Shares Soar 10% After ₹216 Crore Block Deal

• Cohance Lifesciences Ltd. shares surged over 10% following a significant block deal on Wednesday, February 18.
• Approximately 70 lakh shares, representing 1.82% of its equity, valued at ₹216.3 crore, were traded.
• The company reported a 76% decline in net profit to ₹36.7 crore in Q3, with revenue dropping 19.5% to ₹544.5 crore.
• EBITDA fell 60% to ₹95.2 crore, and margins contracted sharply to 17.5% from 35% year-on-year.
• Despite recent declines, the stock hit an intraday high of ₹341 apiece after the block deal.